Clinical trials
Anemia trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Terminated | 9 |
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 10 |
| Amgen | 6 |
| Celgene | 5 |
| Novartis Pharmaceuticals | 4 |
| Abbott Medical Devices | 2 |
| Astellas Pharma Europe B.V. | 2 |
| CTI BioPharma | 2 |
| GlaxoSmithKline | 2 |
| Shire | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 52 |
| Myelodysplastic Syndromes | 10 |
| Renal Insufficiency, Chronic | 10 |
| Primary Myelofibrosis | 7 |
| Hematologic Diseases | 5 |
| Kidney Failure, Chronic | 4 |
| Myeloproliferative Disorders | 4 |
| Thrombocytopenia | 4 |
| Bone Marrow Diseases | 3 |
| Iron Deficiencies | 3 |
Trials
Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.